(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) dropped by a staggering 32.14% in 21 sessions from €2.8 to €1.90 at 20:52 EST on Friday, following the last session’s downward trend. CAC 40 is rising 0.52% to €7,519.61, after four successive sessions in a row of gains. About GENEURO GeNeuro SA, a clinical-stage biopharmaceutical company,…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) dropped by a staggering 33.93% in 21 sessions from €2.8 to €1.85 at 17:52 EST on Thursday, following the last session’s upward trend. CAC 40 is jumping 1.05% to €7,474.82, after three successive sessions in a row of gains. About GENEURO GeNeuro SA, a clinical-stage biopharmaceutical company,…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) fell by a staggering 30.74% in 21 sessions from €2.83 to €1.96 at 11:53 EST on Wednesday, after four sequential sessions in a row of losses. CAC 40 is jumping 0.35% to €7,416.40, after two consecutive sessions in a row of gains. About GENEURO GeNeuro SA, a…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) fell by a staggering 28.57% in 21 sessions from €2.8 to €2.00 at 03:05 EST on Tuesday, after three consecutive sessions in a row of losses. CAC 40 is rising 0.12% to €7,324.75, following the last session’s upward trend. About GENEURO GeNeuro SA, a clinical-stage biopharmaceutical company,…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) dropped by a staggering 28.57% in 21 sessions from €2.8 to €2.00 at 03:05 EST on Monday, after three successive sessions in a row of losses. CAC 40 is jumping 0.12% to €7,324.75, following the last session’s upward trend. About GENEURO GeNeuro SA, a clinical-stage biopharmaceutical company,…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) fell 9.91% to €2.00 at 11:55 EST on Friday, after three successive sessions in a row of losses. CAC 40 is rising 0.12% to €7,324.75, following the last session’s upward trend. This seems, so far, a somewhat up trend exchanging session today. About GENEURO GeNeuro SA, a…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) fell by a staggering 17.86% in 5 sessions from €2.8 to €2.30 at 14:05 EST on Thursday, after five sequential sessions in a row of losses. CAC 40 is sliding 0.28% to €7,110.96, after three consecutive sessions in a row of gains. About GENEURO GeNeuro SA, a…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) dropped by a staggering 17.14% in 5 sessions from €2.8 to €2.32 at 13:56 EST on Tuesday, after five sequential sessions in a row of losses. CAC 40 is jumping 1.71% to €7,133.01, following the last session’s upward trend. About GENEURO GeNeuro SA, a clinical-stage biopharmaceutical company,…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) jumped by a staggering 34.76% in 21 sessions from €2.1 to €2.83 at 16:55 EST on Friday, after three sequential sessions in a row of gains. CAC 40 is falling 1.73% to €7,189.18, after two successive sessions in a row of losses. About GENEURO GeNeuro SA, a…
(VIANEWS) – Shares of GENEURO (CAC 40: GNRO.PA) fell by a staggering 11.43% to €2.48 at 13:56 EST on Monday, following the last session’s upward trend. CAC 40 is jumping 1.65% to €7,305.99, following the last session’s downward trend. This seems, at the moment, an all-around bullish trend trading session today. About GENEURO GeNeuro SA,…
